Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS-Related Complex”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00000653
What this trial is testing

A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 140
Testing effectiveness (Phase 2)Study completedNCT00002357
What this trial is testing

The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

Who this might be right for
HIV Infections
Hoechst Marion Roussel 144
Not applicableStudy completedNCT00000636
What this trial is testing

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 2,000
Not applicableStudy completedNCT00000744
What this trial is testing

A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women

Who this might be right for
CandidiasisCandidiasis, EsophagealHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Not applicableStudy completedNCT00002309
What this trial is testing

Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Pfizer
Not applicableStudy completedNCT00002026
What this trial is testing

Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)

Who this might be right for
Leukoplakia, HairyHIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Early research (Phase 1)Study completedNCT00000986
What this trial is testing

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Early research (Phase 1)Study completedNCT00000739
What this trial is testing

Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Early research (Phase 1)Study completedNCT00002111
What this trial is testing

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

Who this might be right for
HIV Infections
Stanford University 32
Early research (Phase 1)Study completedNCT00000834
What this trial is testing

A Phase I Study of Methotrexate for HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00002107
What this trial is testing

A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients

Who this might be right for
HIV Infections
Chiron Corporation
Large-scale testing (Phase 3)Study completedNCT00002359
What this trial is testing

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

Who this might be right for
HIV Infections
The Immune Response Corporation 3,000
Not applicableStudy completedNCT00002354
What this trial is testing

Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 540
Testing effectiveness (Phase 2)Study completedNCT00002151
What this trial is testing

A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

Who this might be right for
HIV Infections
Hoechst Marion Roussel 200
Testing effectiveness (Phase 2)Study completedNCT00002265
What this trial is testing

An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492

Who this might be right for
HIV Infections
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT00000392
What this trial is testing

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

Who this might be right for
HIV InfectionsCognition Disorders
National Institute of Mental Health (NIMH) 215
Testing effectiveness (Phase 2)Study completedNCT00000848
What this trial is testing

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 144
Early research (Phase 1)Study completedNCT00000669
What this trial is testing

A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT00000770
What this trial is testing

A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Next Page